日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hepatitis B virus, alcohol, and liver cancer

乙型肝炎病毒、酒精和肝癌

Pathania, Anup S; Osna, Natalia A

A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression

一种可扩展的超长效替诺福韦膦酸酯前药可维持乙型肝炎病毒抑制

Raut, Samiksha S; Das, Srijanee; Bybee, Grace; Chava, Haritha; Ogunnaike, Mojisola; Wang, Weimin; Pathania, Anup S; Hanson, Brandon W; Le, Nam Thai Hoang; Cohen, Samuel M; Gendelman, Howard E; Poluektova, Larisa Y; Edagwa, Benson J; Osna, Natalia A

FOXJ3, a novel tumor suppressor in neuroblastoma

FOXJ3,一种神经母细胞瘤中的新型肿瘤抑制因子

Challagundla, Kishore B; Pathania, Anup S; Chava, Haritha; Kantem, Naveenkumar M; Dronadula, Veena M; Coulter, Don W; Clarke, Martina

Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes.

乙醇会破坏巨噬细胞与乙型肝炎病毒感染的肝细胞之间的保护性相互作用

Ganesan Murali, Pathania Anup S, Bybee Grace, Kharbanda Kusum K, Poluektova Larisa Y, Osna Natalia A

Masters of Gene Expression: Transcription Factors in Pediatric Cancers

基因表达大师:儿童癌症中的转录因子

Pathania, Anup S

Hepatic Macrophages in Chronic Hepatitis B: Balancing Immunity and Pathology

慢性乙型肝炎中的肝巨噬细胞:免疫与病理的平衡

Pathania, Anup S; Bhat, Sajad A; Adepoju, Lukman A; Kharbanda, Kusum K; Osna, Natalia A

The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma

miR-29家族通过靶向神经母细胞瘤中的B7-H3免疫检查点促进NK细胞免疫反应的激活。

Pathania, Anup S; Chava, Haritha; Chaturvedi, Nagendra K; Chava, Srinivas; Byrareddy, Siddappa N; Coulter, Don W; Challagundla, Kishore B

The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy

非编码RNA与细胞周期事件的相互作用:癌症治疗的新前沿

Pathania, Anup S; Chava, Haritha; Balusu, Ramesh; Pasupulati, Anil K; Coulter, Don W; Challagundla, Kishore B

Crosstalk between Noncoding RNAs and the Epigenetics Machinery in Pediatric Tumors and Their Microenvironment

儿童肿瘤及其微环境中非编码RNA与表观遗传机制的相互作用

Pathania, Anup S

PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron

PI3K-α/mTOR/BRD4抑制剂单独使用或与其他抗病毒药物联合使用,可阻断SARS-CoV-2及其相关变异株(包括Delta和Omicron)的复制。

Acharya, Arpan; Pathania, Anup S; Pandey, Kabita; Thurman, Michellie; Vann, Kendra R; Kutateladze, Tatiana G; Challagundala, Kishore B; Durden, Donald L; Byrareddy, Siddappa N